Search

Search Constraints

You searched for: Author/Creator Power, Danielle

Search Results

1. Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience. (June 2021)

2. Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data. (March 2022)

3. A machine learning approach using clinical data for recurrence risk-stratification following radiotherapy for non-small cell lung cancer. (March 2022)

4. Combined CT radiomics of primary tumour and metastatic lymph nodes improves prediction of recurrence following radiotherapy for non-small cell lung cancer. (March 2022)

7. CT-radiomics to predict recurrence following curative-intent radiotherapy for stage I–III non-small-cell lung cancer. (November 2022)

8. Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. Issue 3 (25th January 2012)

9. Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy. Issue 2 (February 2020)